Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0008 USD | -96.36% | -.--% | -99.07% |
01-17 | Innovation1 Biotech Inc. Reports Earnings Results for the Full Year Ended August 31, 2023 | CI |
2023 | Innovation1 Biotech Inc. announced that it has received $0.15 million in funding | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Frederick Pierce
CEO | Chief Executive Officer | 63 | 08/09/22 |
Charles Allen
BRD | Director/Board Member | 49 | 04/12/22 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Frederick Pierce
CEO | Chief Executive Officer | 63 | 08/09/22 |
Charles Allen
BRD | Director/Board Member | 49 | 04/12/22 |
Director/Board Member | 70 | 04/12/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 5,389,028 | 0 | 0 | 33.95 % |
Stock B | 0 | 2,694,514 | 0 | 0 | |
Stock C | 1 | 22,470,239 | 7,628,399 ( 33.95 %) | 0 |
Company contact information
Innovation1 Biotech, Inc.
7 Grand View Avenue
02143, Somerville
+
1st Jan change | Capi. | |
---|---|---|
-99.07% | 17.98K | |
+173.89% | 6.55B | |
+5.57% | 1.05B | |
+2.29% | 983M | |
+41.91% | 872M | |
+20.36% | 786M | |
+1.72% | 664M | |
+40.25% | 639M | |
-.--% | 600M | |
-2.15% | 593M |
- Stock Market
- Equities
- IVBT Stock
- Company Innovation1 Biotech Inc.